CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
OPERATING ACTIVITIES
Net income	$ 3,422	$ 184,798
Adjustments for non-cash items:
Depreciation	79,078	72,087
Amortization	10,413	10,780
Stock-based compensation expense	14,289	18,844
Restructuring and asset impairment charges (Notes 7 and 18))	33,792	1,905
Deferred income tax provision (benefit)	(23,597)	2,409
Loss on divestiture (Note 4)	6,517	0
Other	2,748	2,567
Changes in certain assets and liabilities:
Accounts receivable	60,616	(7,595)
Inventories	29,947	(71,814)
Accounts payable and accrued liabilities	(34,351)	(57,165)
Accrued income taxes	(21,957)	5,936
Accrued pension and postretirement benefits	(18,163)	(13,862)
Other	3,305	8,575
Net cash flow provided by operating activities	146,059	157,465
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(206,061)	(145,942)
Disposals of property, plant and equipment	2,780	3,575
Proceeds from divestiture (Note 4)	23,950	0
Other	(869)	(371)
Net cash flow used for investing activities	(180,200)	(142,738)
FINANCING ACTIVITIES
Net decrease in notes payable	(175)	(871)
Net increase (decrease) in short-term revolving and other lines of credit	4,500	(174)
Term debt repayments	0	(400,000)
Purchase of capital stock	(158)	(161)
The effect of employee benefit and stock plans and dividend reinvestment	5,747	5,249
Cash dividends paid to Shareholders	(49,725)	(49,268)
Other	(2,698)	(687)
Net cash flow used for financing activities	(54,003)	(456,410)
Effect of exchange rate changes on cash and cash equivalents	(8,641)	(1,873)
CASH AND CASH EQUIVALENTS
Net decrease in cash and cash equivalents	(96,785)	(443,556)
Cash and cash equivalents, beginning of period	182,015	556,153
Cash and cash equivalents, end of period	$ 85,230	$ 112,597